Update
$Viracta Therapeutics (VIRX.US)$ Viracta Therapeutics Announces Positive Data From the Phase 2 Naval-1 Trial, Regulatory Progress, and Updated Nana-Val Clinical Development Plan
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
ICanBUrSuperman 鸿福平安 : just as you mentioned